Jean-Marie Eveillard – First Eagle U.S. Value Options Positions & Derivatives (Jun 30, 2025)
As of Jun 30, 2025, the First Eagle U.S. Value portfolio disclosed options positions in its latest SEC 13F filing reported on Aug 06, 2025. These filings include call and put options tied to underlying equity holdings, providing a deeper look at the fund's use of derivatives for exposure and hedging.
The reported options activity included 101 call contracts and 21 put contracts across companies such as iShares iBoxx $ High Yield Corp (HYG), Invesco QQQ Trust, Series 1 (QQQ), SPDR Gold Trust (GLD). Options positions can signal strategies around hedging risk, enhancing leverage, or adjusting portfolio exposure during market shifts.
First Eagle U.S. Value Options Activity
Date | Symbol | Option | Quantity |
---|---|---|---|
Q2 2017 | ADNT Adient | CALL | 279 |
Q2 2017 | AEM Agnico Eagle Mines Limited | CALL | 1,000 |
Q2 2017 | ALB Albemarle Corporation | CALL | 1,000 |
Q2 2017 | BALL Ball Corporation | CALL | 300 |
Q2 2017 | DAL Delta Air Lines, Inc. | CALL | 2,000 |
Q2 2017 | G97822103 Perrigo | CALL | 4,800 |
Q2 2017 | GILD Gilead Sciences, Inc. | CALL | 300 |
Q1 2017 | AEM Agnico Eagle Mines Limited | CALL | 1,000 |
Q1 2017 | BIIB Biogen Inc. | CALL | 1,000 |
Q1 2017 | G97822103 Perrigo | CALL | 4,800 |
Q1 2017 | GILD Gilead Sciences, Inc. | CALL | 300 |
Q4 2016 | GILD Gilead Sciences, Inc. | CALL | 300 |
Q4 2016 | SRPT Sarepta Therapeutics, Inc. | CALL | 300 |
Q3 2016 | GILD Gilead Sciences, Inc. | CALL | 300 |
Q3 2016 | SRPT Sarepta Therapeutics, Inc. | CALL | 300 |
Q4 2015 | HPE Hewlett Packard Enterprise Comp | CALL | 2,000 |
Q4 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 3,259 |
Q3 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 6,517 |
Q3 2015 | SPY SPDR S&P 500 | CALL | 2,275 |
Q2 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,017 |
Q1 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,017 |
Q4 2014 | EWH iShares MSCI Hong Kong Index Fu | PUT | 1,000 |
Q4 2014 | GILD Gilead Sciences, Inc. | CALL | 1,200 |
Q4 2014 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,017 |
Q3 2014 | EWH iShares MSCI Hong Kong Index Fu | PUT | 1,000 |
Q3 2014 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,000 |
Q2 2014 | SGMO Sangamo Therapeutics, Inc. | CALL | 2,500 |
Q1 2014 | GERN Geron Corporation | CALL | 2,013 |
Q1 2014 | SUP Superior Industries Internation | CALL | 520 |
Q4 2013 | GERN Geron Corporation | CALL | 6,511 |